GLP-1R Agonist Treatment for Opioid Use Disorder

NCT06548490 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder
Opioid Abuse and Addiction
Narcotic-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorder
Opioid

Interventions

DRUG: Semaglutide Pen Injector
DRUG: Placebo

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]
[object Object]
[object Object]